These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 28003019)

  • 1. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro.
    Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O
    BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cells.
    Hinsche O; Girgert R; Emons G; Gründker C
    Int J Oncol; 2015 Feb; 46(2):878-84. PubMed ID: 25420519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells.
    Schüler-Toprak S; Moehle C; Skrzypczak M; Ortmann O; Treeck O
    BMC Cancer; 2017 May; 17(1):319. PubMed ID: 28482871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a combined treatment with tamoxifen and estrogen receptor β agonists on human breast cancer cell lines.
    Lattrich C; Schüler S; Häring J; Skrzypczak M; Ortmann O; Treeck O
    Arch Gynecol Obstet; 2014 Jan; 289(1):163-71. PubMed ID: 23907354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Kim JE; Han J; Kim TH; Jang SW
    Cell Physiol Biochem; 2019; 52(3):468-485. PubMed ID: 30873822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor β agonists affect growth and gene expression of human breast cancer cell lines.
    Lattrich C; Stegerer A; Häring J; Schüler S; Ortmann O; Treeck O
    Steroids; 2013 Feb; 78(2):195-202. PubMed ID: 23153457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH4 is a potential therapeutic target for triple-negative breast cancer.
    Nagamatsu I; Onishi H; Matsushita S; Kubo M; Kai M; Imaizumi A; Nakano K; Hattori M; Oda Y; Tanaka M; Katano M
    Anticancer Res; 2014 Jan; 34(1):69-80. PubMed ID: 24403446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan hydroxylase 1 and 5-HT
    Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
    Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances the Anti-invasive Efficacy of Selective ERβ Agonists.
    Schmitz V; Bauerschmitz G; Gallwas J; Gründker C
    Anticancer Res; 2022 Nov; 42(11):5187-5194. PubMed ID: 36288854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of estrogen receptor β increases proliferation and affects the transcriptome of endometrial adenocarcinoma cells.
    Treeck O; Diepolder E; Skrzypczak M; Schüler-Toprak S; Ortmann O
    BMC Cancer; 2019 Jul; 19(1):745. PubMed ID: 31357971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
    Tilli TM; Carels N; Tuszynski JA; Pasdar M
    Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence and impact of estrogen metabolism on the biology of triple-negative breast cancer.
    McNamara KM; Oguro S; Omata F; Kikuchi K; Guestini F; Suzuki K; Yang Y; Abe E; Hirakawa H; Brown KA; Takanori I; Ohuchi N; Sasano H
    Breast Cancer Res Treat; 2017 Jan; 161(2):213-227. PubMed ID: 27848152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer.
    Jovanović B; Beeler JS; Pickup MW; Chytil A; Gorska AE; Ashby WJ; Lehmann BD; Zijlstra A; Pietenpol JA; Moses HL
    Breast Cancer Res; 2014 Jul; 16(4):R69. PubMed ID: 24985072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.
    Ma R; Karthik GM; Lövrot J; Haglund F; Rosin G; Katchy A; Zhang X; Viberg L; Frisell J; Williams C; Linder S; Fredriksson I; Hartman J
    J Natl Cancer Inst; 2017 Mar; 109(3):1-14. PubMed ID: 28376210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer.
    Alexandrova E; Lamberti J; Saggese P; Pecoraro G; Memoli D; Cappa VM; Ravo M; Iorio R; Tarallo R; Rizzo F; Collina F; Cantile M; Bonito MD; Botti G; Nassa G; Weisz A; Giurato G
    Cells; 2020 Apr; 9(4):. PubMed ID: 32260128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KR-33028, a potent inhibitor of the Na
    Amith SR; Wilkinson JM; Fliegel L
    Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study.
    Wisinski KB; Xu W; Tevaarwerk AJ; Saha S; Kim K; Traynor A; Dietrich L; Hegeman R; Patel D; Blank J; Harter J; Burkard ME
    Clin Breast Cancer; 2016 Aug; 16(4):256-61. PubMed ID: 27133732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
    Piperigkou Z; Franchi M; Götte M; Karamanos NK
    Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.